While you may be going booze-free to start the year, that doesn’t mean you can’t jazz up your non-alcoholic drinks.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirty-one ratings firms that are covering the firm, ...

This was the stock's third consecutive day of gains.

Fintel reports that on January 3, 2025, Raymond James downgraded their outlook for Vertex (NasdaqGM:VERX) from Outperform to ...

Raymond James downgraded Vertex (VERX) to Market Perform from Outperform without a price target The firm repositioned several ratings ...

Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Mako Mining (TSXV: MKO; OTCQX: MAKOF) this week said it intends to acquire 100% of the Moss gold mine in Arizona from EG ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

A member of the IBD Big Cap 20, Vertex is a top stock to consider after impressive growth last year. VERX stock could present ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.